BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35511114)

  • 1. Prognostic Value of Different Versions of the Model for End-Stage Liver Disease Score in Patients Undergoing Percutaneous Coronary Intervention.
    He HM; He C; You ZB; Zhang SC; Lin XQ; Luo MQ; Lin MQ; Zhang LW; Lin KY; Guo YS
    Angiology; 2023 Feb; 74(2):159-170. PubMed ID: 35511114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Different Versions of the Model for End-Stage Liver Disease Score and Contrast-Associated Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.
    He HM; He C; You ZB; Zhang SC; Lin XQ; Luo MQ; Lin MQ; Zhang LW; Guo YS; Lin KY
    Circ J; 2022 Apr; 86(5):821-830. PubMed ID: 34937817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure.
    Liao S; Lu X; Cheang I; Zhu X; Yin T; Yao W; Zhang H; Li X
    BMC Cardiovasc Disord; 2021 Mar; 21(1):128. PubMed ID: 33750318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of MELD-XI in elderly patients with ST-segment elevation myocardial infarction: an observational study.
    He SJ; Weng JX; Chen HJ; Li HQ; Guo WQ; Cao Q; Xu S; Yan HB; Peng CN
    BMC Cardiovasc Disord; 2021 Jan; 21(1):53. PubMed ID: 33509076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
    BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of modified model for end-stage liver disease scores in patients with significant tricuspid regurgitation.
    Lv J; Ye Y; Li Z; Zhang B; Liu Q; Zhao Q; Zhao Z; Wang W; Zhang H; Duan Z; Wang B; Yu Z; Guo S; Zhao Y; Gao R; Xu H; Wu Y;
    Eur Heart J Qual Care Clin Outcomes; 2023 Apr; 9(3):227-239. PubMed ID: 35612991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid Annuloplasty.
    Chen Y; Liu YX; Seto WK; Wu MZ; Yu YJ; Lam YM; Au WK; Chan D; Sit KY; Ho LM; Tse HF; Yiu KH
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30006492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined value of left ventricular ejection fraction and the Model for End-Stage Liver Disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention.
    Kırıs T; Avcı E; Çelik A
    BMC Cardiovasc Disord; 2018 Mar; 18(1):44. PubMed ID: 29499644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
    Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    Wernly B; Lichtenauer M; Franz M; Kabisch B; Muessig J; Masyuk M; Hoppe UC; Kelm M; Jung C
    PLoS One; 2017; 12(2):e0170987. PubMed ID: 28151948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Value of the Model for End-Stage Liver Disease Score Excluding International Normalized Ratio One Year After Orthotopic Heart Transplantation.
    Szyguła-Jurkiewicz B; Zakliczyński M; Szczurek W; Nadziakiewicz P; Gąsior M; Zembala M
    Transplant Proc; 2016 Jun; 48(5):1703-7. PubMed ID: 27496475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of the coexistence of hepato-renal dysfunction and frailty in patients with heart failure.
    Noda T; Kamiya K; Hamazaki N; Nozaki K; Ichikawa T; Yamashita M; Uchida S; Maekawa E; Terada T; Reed JL; Yamaoka-Tojo M; Matsunaga A; Ako J
    J Cardiol; 2023 Feb; 81(2):215-221. PubMed ID: 36167755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified model for end-stage liver disease score predicts 30-day mortality in high-risk patients with acute pulmonary embolism admitted to intensive care units.
    İdin K; Dereli S; Kaya A; Yenerçağ M; Yılmaz AS; Tayfur K; Gülcü O
    Scand Cardiovasc J; 2021 Aug; 55(4):237-244. PubMed ID: 33491501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of the MELD-XI score for short- and long-term mortality in elderly patients with non-ST elevation myocardial infarction.
    Çınar T; Şaylık F; Selçuk M; Akbulut T; Orhan AL
    Aging Clin Exp Res; 2022 Apr; 34(4):887-895. PubMed ID: 34648172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the MELD-XI score in patients undergoing cardiac resynchronization therapy.
    Saito Y; Nakai T; Ikeya Y; Kogawa R; Otsuka N; Wakamatsu Y; Kurokawa S; Ohkubo K; Nagashima K; Okumura Y
    ESC Heart Fail; 2022 Apr; 9(2):1080-1089. PubMed ID: 34983080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of Hepatic and Renal Dysfunction Based on the Models for End-Stage Liver Disease in Patients With Heart Failure Evaluated for Heart Transplant.
    Szyguła-Jurkiewicz B; Nadziakiewicz P; Zakliczynski M; Szczurek W; Chraponski J; Zembala M; Gasior M
    Transplant Proc; 2016 Jun; 48(5):1756-60. PubMed ID: 27496486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin-bilirubin score is superior to platelet-albumin-bilirubin score and model for end-state liver disease sodium for predicting posthepatectomy liver failure.
    Wong WG; Perez Holguin RA; Tarren AY; Shen C; Vining C; Peng JS; Dixon ME
    J Surg Oncol; 2022 Sep; 126(4):667-679. PubMed ID: 35726364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction in infective endocarditis by modified MELD-XI score.
    He PC; Wei XB; Luo SN; Chen XL; Ke ZH; Yu DQ; Chen JY; Liu YH; Tan N
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1243-1250. PubMed ID: 29594801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure.
    Xun YH; Shi JP; Li CQ; Li D; Shi WZ; Pan QC; Guo JC; Zang GQ
    Mol Med Rep; 2014 May; 9(5):1559-68. PubMed ID: 24573151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the predictive value of the model for end-stage liver disease scoring system combined with the indocyanine green clearance test for short-term prognosis of acute-on-chronic hepatitis B liver failure].
    Tang K; Shan J; Tian F; Cao W
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):190-4. PubMed ID: 24824120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.